Boothbay Fund Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Boothbay Fund Management’s Portfolio CDIOW Stock Details CDIOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Hold	60,540	–	–	﹤0.01%	2007
2026 Q1	$118K	Hold	60,540	–	–	﹤0.01%	1859
2025 Q4	$164K	Hold	60,540	–	–	﹤0.01%	1696
2025 Q3	$243K	Hold	60,540	–	–	﹤0.01%	1562
2025 Q2	$218K	Hold	60,540	–	–	﹤0.01%	1215
2025 Q1	$20K	Hold	60,540	–	–	﹤0.01%	1334
2024 Q4	$55.5K	Hold	60,540	–	–	﹤0.01%	1346
2024 Q3	$13.5K	Hold	60,540	–	–	﹤0.01%	1555
2024 Q2	$33.3K	Hold	60,540	–	–	﹤0.01%	1436
2024 Q1	$86K	Hold	60,540	–	–	﹤0.01%	1436
2023 Q4	$151K	Hold	60,540	–	–	﹤0.01%	1378
2023 Q3	$20.6K	Hold	60,540	–	–	﹤0.01%	1662
2023 Q2	$72K	Hold	60,540	–	–	﹤0.01%	1651
2023 Q1	$237K	Sell	60,540 -39,460	-39%	-$9.26K	﹤0.01%	1646
2022 Q4	$106K	Buy	+100,000	New	+$11.9K	﹤0.01%	1771
2022 Q3	–	Sell	-100,000	Closed	-$993K	–	2269
2022 Q2	$993K	Hold	100,000	–	–	0.03%	811
2022 Q1	$977K	Buy	+100,000	New	+$23.8K	0.02%	918

Other funds holding CDIOW

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boothbay Fund Management's CDIOW Position: Q2 2026 in Review

Boothbay Fund Management held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q2 2026 at 60,540 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Boothbay Fund Management first reported a position in CDIOW in Q1 2022 and has held it in 17 quarters since. The position peaked at $993K in Q2 2022. 7 funds tracked by Wall St. Rank hold CDIOW as of Q2 2026.

Boothbay Fund Management held 60,540 shares of Cardio Diagnostics Holdings Inc Warrant worth $133K as of Q2 2026.
Boothbay Fund Management left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q2 2026.
Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2007 holding.
Boothbay Fund Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and has held it in 17 quarters since.
Boothbay Fund Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $993K in Q2 2022.
7 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.